Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-23-021417

President, R&D sold 763 shares at $15.36 ($11,720)

From the SEC's structured data for this filing

Trades in this filing

Bergstrom Donald A · President, R&D

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-03-27 Sale : show line 1 in the form −763 $15.36 $11,720 244,084 D
Open-market sales · 763 sh · avg $15.36 · $11,720
Loading xslF345X04/doc4.xml…